Firmenbeschreibung
Moderna Inc. ist ein US amerikanisches Biotech-Unternehmen, das sich auf die Forschung und Entwicklung von Arzneimitteln auf Basis von mRNA spezialisiert. mRNA-Arzneien sind darauf ausgelegt, dass körpereigene Zellen Proteine mit therapeutischer oder vorbeugender Wirkung produzieren, die bei der Behandlung einer Vielzahl von Krankheiten helfen können. Die Anwendungsgebiete für mRNA-Produkte umfassen Therapeutika und Impfstoffe für Krebsimmuntherapien, seltene Krankheiten, Herz-Kreislauf-Erkrankungen, Autoimmunerkrankungen und Entzündungen. Die beständigen Fortschritte des Unternehmens in der Grundlagen- und angewandten mRNA-Forschung ermöglichen parallele Neuentwicklungen, sowohl unabhängig als auch mit strategischen Partnern zusammen. Es bestehen strategische Partnerschaften mit AstraZeneca PLC und Merck & Co., außerdem mit verschiedenen US-Behörden und Forschungseinrichtungen.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Freefloat (74.9%),Baillie Gifford and Co. (11.4%),BlackRock, Inc. (6.9%),The Vanguard Group (6.8%) |
| sharesOutstanding: | 384180469.0000 |
| ceo: | Stéphane Bancel |
| board: | David Meline, Corinne Le Goff, Juan Andres, Kate Cronin, Marcello Damiani, Paul Burton, M.D., Shannon Thyme Klinger, Stephen Hoge, M.D., Tracey Franklin |
| supervisoryBoard: | Dr. Noubar Afeyan, Elizabeth Nabel, M.D., Elizabeth Tallett, François Nader, M.D., Henri A. Termeer, Paul Sagan, Robert Langer, Sandra Horning, M.D., Stéphane Bancel, Stephen Berenson |
| countryID: | 20 |
| faceValue: | 0.0001 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Biotechnologie |
| industryName: | Biotechnologie |
| subsectorName: | Biotechnologie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Lavina Talukdar |
| phone: | +1-617-209-5834 |
| email: | IR@modernatx.com |
| irWebSite: | https://investors.modernatx.com/ |
Adresse
| street: | 200 Technology Square |
| city: | Cambridge, Massachusetts 02139, USA |
| phone: | +1-617-714-6500 |
| fax: | +1-617-583-1998 |
| webSite: | https://www.modernatx.com/ |
| email: | info@modernatx.com |
Finanzen (kurz)
| year: | 2020 | cash: | 2623.8500 |
| balanceSheetTotal: | 7336.7500 | liabilities: | 4775.3750 |
| totalShareholdersEquity: | 2561.3750 | sales: | 803.3950 |
| investment: | 24.7000 | incomeBeforeTaxes: | -744.5130 |
| netIncome: | -747.0640 | cashFlow: | 2388.2360 |
| employees: | 1300 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2021 | cash: | 6848.0000 |
| balanceSheetTotal: | 24669.0000 | liabilities: | 10524.0000 |
| totalShareholdersEquity: | 14145.0000 | sales: | 18471.0000 |
| investment: | 18.0000 | incomeBeforeTaxes: | 13285.0000 |
| netIncome: | 12202.0000 | cashFlow: | 4224.0000 |
| employees: | 2700 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 3205.0000 |
| balanceSheetTotal: | 25858.0000 | liabilities: | 6735.0000 |
| totalShareholdersEquity: | 19123.0000 | sales: | 19263.0000 |
| incomeBeforeTaxes: | 9575.0000 | netIncome: | 8362.0000 |
| cashFlow: | -3643.0000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
Finanzen (kurz)
| year: | 2020 |
| cash: | 2623.8500 |
| balanceSheetTotal: | 7336.7500 |
| liabilities: | 4775.3750 |
| totalShareholdersEquity: | 2561.3750 |
| sales: | 803.3950 |
| investment: | 24.7000 |
| incomeBeforeTaxes: | -744.5130 |
| netIncome: | -747.0640 |
| cashFlow: | 2388.2360 |
| employees: | 1300 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2021 |
| cash: | 6848.0000 |
| balanceSheetTotal: | 24669.0000 |
| liabilities: | 10524.0000 |
| totalShareholdersEquity: | 14145.0000 |
| sales: | 18471.0000 |
| investment: | 18.0000 |
| incomeBeforeTaxes: | 13285.0000 |
| netIncome: | 12202.0000 |
| cashFlow: | 4224.0000 |
| employees: | 2700 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 3205.0000 |
| balanceSheetTotal: | 25858.0000 |
| liabilities: | 6735.0000 |
| totalShareholdersEquity: | 19123.0000 |
| sales: | 19263.0000 |
| incomeBeforeTaxes: | 9575.0000 |
| netIncome: | 8362.0000 |
| cashFlow: | -3643.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 | units: | 1000000 |
| balanceSheetTotal: | 24669.0000 | cash: | 6848.0000 |
| currentAssets: | 16071.0000 | fixedAssets: | 8598.0000 |
| liabilities: | 9128.0000 | totalLiabilitiesEquity: | 24669.0000 |
| provisions: | 1472.0000 | totalShareholdersEquity: | 14145.0000 |
| employees: | 2700 | property: | 1241.0000 |
| longTermInvestments: | 6843.0000 | inventories: | 1441.0000 |
| accountsReceivable: | 3175.0000 | accountsPayable: | 302.0000 |
| liabilitiesTotal: | 10524.0000 | longTermDebt: | 599.0000 |
| sales: | 18471.0000 | netIncome: | 12202.0000 |
| operatingResult: | 13296.0000 | incomeInterest: | 18.0000 |
| investments: | 1991.0000 | incomeTaxes: | 1083.0000 |
| costGoodsSold: | 2617.0000 | grossProfit: | 15854.0000 |
| revenuePerEmployee: | 6841111.1111 | cashFlow: | 13620.0000 |
| cashFlowInvesting: | -8523.0000 | cashFlowFinancing: | -873.0000 |
| cashFlowTotal: | 4224.0000 | accountingStandard: | US GAAP |
| equityRatio: | 57.3392 | debtEquityRatio: | 74.4008 |
| liquidityI: | 75.0219 | liquidityII: | 109.8050 |
| netMargin: | 66.0603 | grossMargin: | 85.8318 |
| cashFlowMargin: | 73.7372 | ebitMargin: | 71.9831 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 93.9201 |
| preTaxROA: | 53.8530 | roe: | 86.2637 |
| roa: | 49.4629 | revenuesGrowth: | 2199.1181 |
| taxExpenseRate: | 8.1521 | equityTurnover: | 1.3058 |
| epsBasic: | 30.3100 | epsDiluted: | 28.2900 |
| incomeBeforeTaxes: | 13285.0000 | priceEarningsRatioCompany: | 8.3794 |
| priceCashFlowRatio: | 7.5126 | bookValuePerShare: | 35.1103 |
| marketCap: | 102321680984.2800 | earningsYield: | 11.9340 |
| cashFlowPerShare: | 33.8072 | priceBookValueRatio: | 7.2338 |
| priceEarningsRatio: | 8.3856 | netEarningsPerShare: | 30.2875 |
| currency: | USD |
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 25858.0000 | cash: | 3205.0000 |
| currentAssets: | 13431.0000 | fixedAssets: | 12427.0000 |
| liabilities: | 4923.0000 | totalLiabilitiesEquity: | 25858.0000 |
| totalShareholdersEquity: | 19123.0000 | property: | 2018.0000 |
| longTermInvestments: | 8318.0000 | inventories: | 949.0000 |
| accountsReceivable: | 1385.0000 | accountsPayable: | 487.0000 |
| liabilitiesTotal: | 6735.0000 | longTermDebt: | 912.0000 |
| sales: | 19263.0000 | netIncome: | 8362.0000 |
| operatingResult: | 9420.0000 | incomeInterest: | 200.0000 |
| investments: | 3295.0000 | incomeTaxes: | 1213.0000 |
| costGoodsSold: | 5416.0000 | grossProfit: | 13847.0000 |
| cashFlow: | 4981.0000 | cashFlowInvesting: | -5176.0000 |
| cashFlowFinancing: | -3448.0000 | cashFlowTotal: | -3643.0000 |
| accountingStandard: | US GAAP | equityRatio: | 73.9539 |
| debtEquityRatio: | 35.2194 | liquidityI: | 65.1026 |
| liquidityII: | 93.2358 | netMargin: | 43.4096 |
| grossMargin: | 71.8839 | cashFlowMargin: | 25.8579 |
| ebitMargin: | 48.9020 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 50.0706 | preTaxROA: | 37.0292 |
| roe: | 43.7274 | roa: | 32.3382 |
| netIncomeGrowth: | -31.4703 | revenuesGrowth: | 4.2878 |
| taxExpenseRate: | 12.6684 | equityTurnover: | 1.0073 |
| epsBasic: | 21.2600 | epsDiluted: | 20.1200 |
| epsBasicGrowth: | -29.8581 | incomeBeforeTaxes: | 9575.0000 |
| priceEarningsRatioCompany: | 8.4487 | priceCashFlowRatio: | 13.9318 |
| bookValuePerShare: | 49.4979 | marketCap: | 69394317874.2800 |
| earningsYield: | 11.8361 | pegRatio: | -0.2830 |
| cashFlowPerShare: | 12.8928 | priceBookValueRatio: | 3.6288 |
| priceEarningsRatio: | 8.2988 | netEarningsPerShare: | 21.6442 |
| currency: | USD |
| year: | 2023 | priceEarningsRatioCompany: | 7.2010 |
| priceCashFlowRatio: | 11.8744 | bookValuePerShare: | 49.4979 |
| marketCap: | 59146157901.9578 | earningsYield: | 13.8869 |
| pegRatio: | -0.2412 | cashFlowPerShare: | 12.8928 |
| netAssetsPerShare: | 49.4979 | priceBookValueRatio: | 3.0929 |
| priceEarningsRatio: | 7.0732 | netEarningsPerShare: | 21.6442 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 |
| units: | 1000000 |
| balanceSheetTotal: | 24669.0000 |
| cash: | 6848.0000 |
| currentAssets: | 16071.0000 |
| fixedAssets: | 8598.0000 |
| liabilities: | 9128.0000 |
| totalLiabilitiesEquity: | 24669.0000 |
| provisions: | 1472.0000 |
| totalShareholdersEquity: | 14145.0000 |
| employees: | 2700 |
| property: | 1241.0000 |
| longTermInvestments: | 6843.0000 |
| inventories: | 1441.0000 |
| accountsReceivable: | 3175.0000 |
| accountsPayable: | 302.0000 |
| liabilitiesTotal: | 10524.0000 |
| longTermDebt: | 599.0000 |
| sales: | 18471.0000 |
| netIncome: | 12202.0000 |
| operatingResult: | 13296.0000 |
| incomeInterest: | 18.0000 |
| investments: | 1991.0000 |
| incomeTaxes: | 1083.0000 |
| costGoodsSold: | 2617.0000 |
| grossProfit: | 15854.0000 |
| revenuePerEmployee: | 6841111.1111 |
| cashFlow: | 13620.0000 |
| cashFlowInvesting: | -8523.0000 |
| cashFlowFinancing: | -873.0000 |
| cashFlowTotal: | 4224.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 57.3392 |
| debtEquityRatio: | 74.4008 |
| liquidityI: | 75.0219 |
| liquidityII: | 109.8050 |
| netMargin: | 66.0603 |
| grossMargin: | 85.8318 |
| cashFlowMargin: | 73.7372 |
| ebitMargin: | 71.9831 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 93.9201 |
| preTaxROA: | 53.8530 |
| roe: | 86.2637 |
| roa: | 49.4629 |
| revenuesGrowth: | 2199.1181 |
| taxExpenseRate: | 8.1521 |
| equityTurnover: | 1.3058 |
| epsBasic: | 30.3100 |
| epsDiluted: | 28.2900 |
| incomeBeforeTaxes: | 13285.0000 |
| priceEarningsRatioCompany: | 8.3794 |
| priceCashFlowRatio: | 7.5126 |
| bookValuePerShare: | 35.1103 |
| marketCap: | 102321680984.2800 |
| earningsYield: | 11.9340 |
| cashFlowPerShare: | 33.8072 |
| priceBookValueRatio: | 7.2338 |
| priceEarningsRatio: | 8.3856 |
| netEarningsPerShare: | 30.2875 |
| currency: | USD |
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 25858.0000 |
| cash: | 3205.0000 |
| currentAssets: | 13431.0000 |
| fixedAssets: | 12427.0000 |
| liabilities: | 4923.0000 |
| totalLiabilitiesEquity: | 25858.0000 |
| totalShareholdersEquity: | 19123.0000 |
| property: | 2018.0000 |
| longTermInvestments: | 8318.0000 |
| inventories: | 949.0000 |
| accountsReceivable: | 1385.0000 |
| accountsPayable: | 487.0000 |
| liabilitiesTotal: | 6735.0000 |
| longTermDebt: | 912.0000 |
| sales: | 19263.0000 |
| netIncome: | 8362.0000 |
| operatingResult: | 9420.0000 |
| incomeInterest: | 200.0000 |
| investments: | 3295.0000 |
| incomeTaxes: | 1213.0000 |
| costGoodsSold: | 5416.0000 |
| grossProfit: | 13847.0000 |
| cashFlow: | 4981.0000 |
| cashFlowInvesting: | -5176.0000 |
| cashFlowFinancing: | -3448.0000 |
| cashFlowTotal: | -3643.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 73.9539 |
| debtEquityRatio: | 35.2194 |
| liquidityI: | 65.1026 |
| liquidityII: | 93.2358 |
| netMargin: | 43.4096 |
| grossMargin: | 71.8839 |
| cashFlowMargin: | 25.8579 |
| ebitMargin: | 48.9020 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 50.0706 |
| preTaxROA: | 37.0292 |
| roe: | 43.7274 |
| roa: | 32.3382 |
| netIncomeGrowth: | -31.4703 |
| revenuesGrowth: | 4.2878 |
| taxExpenseRate: | 12.6684 |
| equityTurnover: | 1.0073 |
| epsBasic: | 21.2600 |
| epsDiluted: | 20.1200 |
| epsBasicGrowth: | -29.8581 |
| incomeBeforeTaxes: | 9575.0000 |
| priceEarningsRatioCompany: | 8.4487 |
| priceCashFlowRatio: | 13.9318 |
| bookValuePerShare: | 49.4979 |
| marketCap: | 69394317874.2800 |
| earningsYield: | 11.8361 |
| pegRatio: | -0.2830 |
| cashFlowPerShare: | 12.8928 |
| priceBookValueRatio: | 3.6288 |
| priceEarningsRatio: | 8.2988 |
| netEarningsPerShare: | 21.6442 |
| currency: | USD |
| year: | 2023 |
| priceEarningsRatioCompany: | 7.2010 |
| priceCashFlowRatio: | 11.8744 |
| bookValuePerShare: | 49.4979 |
| marketCap: | 59146157901.9578 |
| earningsYield: | 13.8869 |
| pegRatio: | -0.2412 |
| cashFlowPerShare: | 12.8928 |
| netAssetsPerShare: | 49.4979 |
| priceBookValueRatio: | 3.0929 |
| priceEarningsRatio: | 7.0732 |
| netEarningsPerShare: | 21.6442 |
| currency: | USD |
